DSGN Design Therapeutics, Inc.
NEUTRAL
Impact: 2/10
3
Form 3 — initial insider ownership statement
Latest settled — T+20d
DSGN ▲ +21.10% at T+20d
NEUTRAL call ✓ call won +21.10% · α vs SPY +11.23% · entry $11.23 → $13.60
Last close $10.97 (close Jun 12) · -2.32% from $11.23 entry
T+1d
+11.58%
call +11.58% · α +11.10%
$12.53
settled 2mo ago
T+5d
+8.28%
call +8.28% · α +4.66%
$12.16
settled 2mo ago
T+20d
+21.10%
call +21.10% · α +11.23%
$13.60
settled 7w ago
T+60d
—
call — · α —
—
in 14d
Price Chart
Loading chart...
Executive Summary
David Shapiro, a director or 10% owner of Design Therapeutics, Inc., filed a Form 3 to report his initial beneficial ownership and appointed Sean Jeffries and Mustapha Parekh as attorneys-in-fact to file SEC Forms 3, 4, and 5 on his behalf. This is a routine compliance filing related to insider reporting obligations.
Actionable Insight
This is a standard regulatory filing with no immediate trading implications. Traders should monitor future Form 4 filings for any actual insider buying or selling activity.
Key Facts
- David Shapiro filed Form 3 as a director or 10% shareholder of DSGN.
- He granted power of attorney to Sean Jeffries and Mustapha Parekh to file SEC Forms 3, 4, and 5 on his behalf.
- The filing was made on April 1, 2026, with a reporting period end date of March 31, 2026.
- No transactions or changes in ownership were disclosed in this filing.
Financial Impact
No financial impact disclosed
Risk Factors
- None identified from this filing
- Lack of disclosed ownership details limits insight into potential future insider transactions
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001559570-26-000004 |
| Document: 0001559570-26-000004-index-headers.html | 0001559570-26-000004 |
| Document: 0001559570-26-000004-index.html | 0001559570-26-000004 |
| Document: 0001559570-26-000004.txt | 0001559570-26-000004 |
6 reports for DSGN
75%
Hit rate
best @ T+5▲ +6.54%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 18, 2026
27d ago
|
8-K
| $10.70 $11.40 | ▲ +6.54% | ▲ +4.92% | $10.97 (+2.52%) |
|
May 18, 2026
27d ago
|
Press Release
| $10.70 $11.40 | ▲ +6.54% | ▲ +4.92% | $10.97 (+2.52%) |
|
May 17, 2026
28d ago
|
Press Release
| $10.70 $11.40 | ▲ +6.54% | ▲ +4.92% | $10.97 (+2.52%) |
|
Apr 28, 2026
6w ago
|
Press Release
| $15.79 $13.41 | ▼ −15.07% | ▼ −18.18% | $10.97 (−30.53%) |
|
Apr 23, 2026
7w ago
|
DEFA14A
| $12.53 $13.60 | ▲ +8.54% | ▲ +7.63% | $10.97 (−12.45%) |
|
Apr 1, 2026
10w ago
|
3
| $11.23 $12.16 | ▲ +8.28% | ▲ +4.66% | $10.97 (−2.32%) |
Showing 6 of 6
US Market Status
Market Closed — Opens in 4h 15m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access